Literature DB >> 21738227

Primary signet ring cell carcinoma of the eyelid in a young woman.

R Khoramnia, C Mayer, E Glaser, G Weirich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21738227      PMCID: PMC3194316          DOI: 10.1038/eye.2011.163

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Signet ring carcinoma of the eccrine sweat gland in the eyelid, treated by radiotherapy alone.

Authors:  C Auw-Haedrich; N Boehm; C Weissenberger
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

Review 2.  Signet ring cell carcinoma of the eccrine sweat glands in the eyelid.

Authors:  G Wollensak; H Witschel; N Böhm
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

3.  Eccrine sweat gland tumor of clear cell origin involving the eyelids.

Authors:  Y Rosen; B Kim; V A Yermakov
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

4.  Signet ring cell carcinoma of the eyelid - the monocle tumour.

Authors:  Anouck Leuba Mortensen; Steffen Heegaard; Ole Clemmensen; Jan Ulrik Prause
Journal:  APMIS       Date:  2008-04       Impact factor: 3.205

5.  Gastric adenocarcinoma presenting as an eyelid and conjunctival mass.

Authors:  M Küchle; L Holbach; U Schlötzer-Schrehardt
Journal:  Eur J Ophthalmol       Date:  1992 Jan-Mar       Impact factor: 1.922

  5 in total
  3 in total

1.  Primary Eccrine Adenocarcinoma: A Rare but Dangerous Lesion of the Eyelid.

Authors:  John Awad; David Cheung
Journal:  J Clin Aesthet Dermatol       Date:  2021-04-01

2.  Sclerosing Signet Ring Cell Carcinoma of the Lacrimal Gland: A Potentially New Primary Entity.

Authors:  Frederick A Jakobiec; Edith R Reshef; Lina Ma; Martin K Selig; Daniel R Lefebvre; Anna M Stagner
Journal:  Ocul Oncol Pathol       Date:  2020-02-07

3.  Diagnostic and treatment challenges of a case of primary cutaneous signet-ring cell/histiocytoid carcinoma of the eyelid.

Authors:  Mathew M Palakkamanil; Muhammad N Mahmood; Audrey Chan
Journal:  BMC Ophthalmol       Date:  2020-10-14       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.